MPA Pharma GmbH

MPA Pharma GmbH is a German pharmaceutical company focused on the re-importation and parallel import of EU-approved medicines, as well as the trade of pharmaceuticals and medical devices. Founded in Germany, MPA Pharma GmbH specializes in the pharmaceutical sector with a focus on the re-importation of EU-approved medicines and medical devices. The company was acquired by Hannover Finanz in 1998, though the financial terms were not disclosed. As part of its operations, MPA Pharma has maintained a presence in markets across Europe, including Germany and Austria.

MPA Pharma GmbH primarily operates in the pharmaceutical sector, specializing in the re-importation and parallel import of EU-approved medicines and the trade of pharmaceuticals and medical devices. Their core competencies include manufacturing pharmaceuticals for third-party companies and distributing both patented and generic products, including over-the-counter (OTC) medications. The company serves various market segments across Europe, ensuring access to high-quality medicines and medical products for healthcare providers, pharmacies, and other pharmaceutical companies in Germany, Austria, and the Scandinavian region. In the most recent year, MPA Pharma GmbH reported a revenue of EUR 432.

76 mn and an EBITDA of EUR 9. 40 mn. Their revenue model is based on B2B transactions, partnering with healthcare providers and pharmacies for the distribution of their pharmaceutical products through direct sales and collaboration with wholesalers. MPA Pharma GmbH is focused on expanding its product offerings and geographic reach.

While specific details regarding new product launches or release dates were not disclosed, the company plans to leverage recent funding to enhance its operations. The acquisition by Hannover Finanz in 1998 marked a pivotal moment for the company, and it aims to further develop its position in the European pharmaceutical market.